Latest News about AZN
Recent news which mentions AZN
Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million
February 20, 2025
From Benzinga
Big Money Is Betting On Europe, Should You? 3 ETFs To Watch
February 19, 2025
From Benzinga
George Soros Makes Fresh Bets On Alphabet, Small Caps: What About SPY Puts And Alibaba?
February 19, 2025
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 18, 2025
From Benzinga
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
February 15, 2025
From Motley Fool
AstraZeneca's Imfinzi Perioperative Regimen Shows Improved Survival Outcomes In Bladder Cancer Patients
February 14, 2025
From Benzinga
From Benzinga
From Benzinga
Trade Desk, Leidos, Devon Energy And A Major Health Care Stock On CNBC's 'Final Trades'
February 12, 2025
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 11, 2025
From Benzinga
AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript
February 06, 2025
Tickers
AZN
From Motley Fool
AstraZeneca Q4 Earnings: Revenue And EPS Beat On Higher Cancer And Respiratory Drug Sales, Faces $4.5 Million Potential Fine In China
February 06, 2025
From Benzinga
Earnings Scheduled For February 6, 2025
February 06, 2025
From Benzinga
AstraZeneca Blames 'Toxic' Climate As It Walks Away from Over $550 Million UK Vaccine Plant
February 03, 2025
From Benzinga
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
January 29, 2025
From Benzinga
FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients
January 28, 2025
From Benzinga
From Benzinga
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
January 22, 2025
From Benzinga
From Benzinga
From Benzinga
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
January 21, 2025
From Motley Fool
AstraZeneca Aims to Restore Trust With New Leadership in China Amid Scandal and Sales Decline
January 17, 2025
From Benzinga
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
January 17, 2025
From Benzinga
FDA Approves AstraZeneca's Calquence Combo Therapy For Untreated Mantle Cell Lymphoma
January 17, 2025
From Benzinga
From Motley Fool
3 Cheap Growth Stocks to Buy in 2025
January 09, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.